Mortes por suicídio 19 vezes maiores após a redesignação sexual do que na população comparável: coorte sueca de 30 anos

Acompanhamento de longo prazo de pessoas transexuais submetidas à cirurgia de redesignação sexual: estudo de coorte na Suécia

Authors
Cecilia Dhejne, Paul Lichtenstein, Marcus Boman, Anna L. V. Johansson, Niklas Långström, Mikael Landén
Journal
PLOS ONE
Year
2011

Summary

Swedish researchers used national records to follow everyone who had sex reassignment surgery and changed legal sex between 1973 and 2003. They compared each person with ten random people of the same age and sex. Over about 11 years, the reassigned group died about three times as often and died by suicide about 19 times as often. They were about five times as likely to attempt suicide and three times as likely to be admitted for psychiatric care, even after allowing for earlier psychiatric admissions. The gaps in deaths and suicide attempts were mainly among people treated before 1989. The authors concluded that surgery, while easing gender distress, is not enough on its own, and better long-term care is needed. Because the comparison was with the general public, not trans people who did not transition, the study cannot say whether surgery made things better or worse.

Key findings

  • Todas as 324 pessoas na Suécia que fizeram cirurgia de redesignação sexual e mudaram o sexo legal entre 1973 e 2003 (191 de homem para mulher, 133 de mulher para homem) foram comparadas com 3.240 pessoas da população em geral do mesmo ano de nascimento e sexo.
  • As mortes por todas as causas foram cerca de 3 vezes maiores do que em pessoas do mesmo sexo de nascimento, com a diferença surgindo após cerca de 10 anos.
  • A morte por suicídio foi cerca de 19 vezes maior, com base em 10 suicídios entre as 324 pessoas contra 5 no grupo de comparação. O valor real é muito incerto (de cerca de 6 a 63 vezes).
  • As tentativas de suicídio foram cerca de 5 vezes maiores e as internações psiquiátricas cerca de 3 vezes maiores, mesmo levando em conta as internações psiquiátricas antes da cirurgia, que eram cerca de 4 vezes mais comuns no grupo redesignado.
  • As mortes por doenças do coração e dos vasos sanguíneos foram um pouco elevadas (cerca de 2,5 vezes; 9 mortes), e as mortes por câncer possivelmente elevadas (cerca de 2 vezes). Os autores alertam que os números eram pequenos e não culparam os hormônios.
  • Para as pessoas tratadas de 1989 a 2003, as mortes extras e as tentativas de suicídio poderiam ser obra do acaso, embora as internações psiquiátricas ainda fossem cerca de 2,5 vezes maiores.
  • Os homens trans (mulher para homem) tiveram mais condenações criminais do que outras mulheres, aproximadamente o mesmo que os homens; as mulheres trans (homem para mulher) não diferiram de outros homens.
  • Os autores dizem que o estudo não pode mostrar se a redesignação sexual funciona como tratamento, e que os resultados poderiam ter sido ainda piores sem ela.

Abstract

Context: The treatment for transsexualism is sex reassignment, including hormonal treatment and surgery aimed at making the person's body as congruent with the opposite sex as possible. There is a dearth of long term, follow-up studies after sex reassignment.

Objective: To estimate mortality, morbidity, and criminal rate after surgical sex reassignment of transsexual persons.

Design: A population-based matched cohort study.

Setting: Sweden, 1973-2003.

Participants: All 324 sex-reassigned persons (191 male-to-females, 133 female-to-males) in Sweden, 1973-2003. Random population controls (10:1) were matched by birth year and birth sex or reassigned (final) sex, respectively.

Main Outcome Measures: Hazard ratios (HR) with 95% confidence intervals (CI) for mortality and psychiatric morbidity were obtained with Cox regression models, which were adjusted for immigrant status and psychiatric morbidity prior to sex reassignment (adjusted HR [aHR]).

Results: The overall mortality for sex-reassigned persons was higher during follow-up (aHR 2.8; 95% CI 1.8-4.3) than for controls of the same birth sex, particularly death from suicide (aHR 19.1; 95% CI 5.8-62.9). Sex-reassigned persons also had an increased risk for suicide attempts (aHR 4.9; 95% CI 2.9-8.5) and psychiatric inpatient care (aHR 2.8; 95% CI 2.0-3.9). Comparisons with controls matched on reassigned sex yielded similar results. Female-to-males, but not male-to-females, had a higher risk for criminal convictions than their respective birth sex controls.

Conclusions: Persons with transsexualism, after sex reassignment, have considerably higher risks for mortality, suicidal behaviour, and psychiatric morbidity than the general population. Our findings suggest that sex reassignment, although alleviating gender dysphoria, may not suffice as treatment for transsexualism, and should inspire improved psychiatric and somatic care after sex reassignment for this patient group.

Conclusion

Persons with transsexualism, after sex reassignment, have considerably higher risks for mortality, suicidal behaviour, and psychiatric morbidity than the general population. Our findings suggest that sex reassignment, although alleviating gender dysphoria, may not suffice as treatment for transsexualism, and should inspire improved psychiatric and somatic care after sex reassignment for this patient group.